CAD & Atherosclerosis
From the Journals
Stiff arteries may cause metabolic syndrome
“It seems metabolic syndrome has a new risk factor we haven’t thought about.”
From the Journals
Vegetarian diets can improve high-risk cardiovascular disease
“This meta-analysis is the first that generates evidence from randomized controlled trials to assess the association of vegetarian diets with...
From the Journals
Gut and oral flora linked to subclinical CAD, inflammation
“Sch bacteria may “contribute to atherogenesis by direct infection or by altering host metabolism.”
From the Journals
Aspirin not the best antiplatelet for CAD secondary prevention in meta-analysis
“Taken together, our data challenge the central role of aspirin in secondary prevention and support a paradigm shift toward P2Y12 inhibitor...
From the Journals
Heart-protective diet in PURE study allows whole-fat dairy
“The new results in PURE, in combination with prior reports, call for a re-evaluation of unrelenting guidelines to avoid whole-fat dairy products...
Latest News
TAVI turmoil: Did an ANP perform transcatheter aortic valve replacement in the U.K.?
Some say such a procedure should only be done by a cardiologist or cardiac surgeon; others say that there is no stopping “scope creep.”
Feature
Does colchicine have a role in treating excess ASCVD risk in patients with chronic inflammatory conditions?
Experts in rheumatology, dermatology, and gastroenterology assess the potential of colchicine 0.5 mg to treat residual risk for atherosclerotic...
Feature
Low-dose colchicine approved for CVD: Now what?
“If we think patients are still at high risk of recurrent cardiovascular events, we have to think what we will do next. This is where this drug...
News from the FDA/CDC
FDA OKs low-dose colchicine for broad CV indication
“The FDA approval of colchicine for patients with atherosclerotic disease is a huge signal that physicians need to be aware of inflammation as a...
From the Journals
AHA flags CV risk with lead, cadmium, and arsenic exposure
“In reality, identifying a new type of cardiovascular risk factor leads to more questions than answers.”
Conference Coverage
High Lp(a) tied to higher coronary plaque volume, progression
This could explain the greater risk for major adverse cardiovascular events seen in patients with high Lp(a) levels.